MORGAN VENTURES LTD.

Morgan Ventures Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Un-audited Financial Results for the quarter ended June 30, 2026. All promoters, directors, designated persons, connected persons, and their immediate relatives are prohibited from trading during this period. The date for the board meeting to approve these financial results will be communicated separately.

Morgan Ventures Ltd has reappointed Mr. Sanjiv Bansal as an Independent Director for a second term of 5 years, effective from June 17, 2026. The reappointment, based on the recommendation of the Nomination and Remuneration Committee and approved by the Board of Directors on May 29, 2026, is subject to the approval of the company's members. Mr. Bansal's new term will last until June 17, 2031.

Morgan Ventures Ltd has reappointed Mr. Sanjiv Bansal as an Independent Director for a second term of 5 years, effective from June 17, 2026, until June 17, 2031. This reappointment is based on the recommendation of the Nomination and Remuneration Committee and the approval of the Board of Directors at their meeting held on May 29, 2026, and is subject to the approval of the company's members. Dr. Bansal is a physician with experience in diagnosing and managing medical conditions and owns Bansal Hospitals in Delhi.

Morgan Ventures Ltd has appointed H. Tara & Co., Practicing Cost Accountants, as the Internal Auditor for the financial year 2026-2027. The appointment was made during the Board of Directors meeting held on May 29, 2026. H. Tara & Co. confirmed they do not suffer from any disqualifications under the Companies Act, 2013 and are an independent firm at arm’s length with the company.

Morgan Ventures Ltd's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026, in a meeting held on May 29, 2026. The board also reviewed the auditor's report with an unmodified opinion. A legal matter concerning land valued at ₹320.02 crore is ongoing, with the company contesting the revocation of lease rights by MIDC in the Bombay High Court. The court has allowed MIDC symbolic possession only, pending the final order.

Morgan Ventures Ltd's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026, in a meeting held on May 29, 2026. The results, along with the auditor's report and declaration regarding the unmodified audit opinion, have been submitted to the stock exchange as per SEBI regulations. The auditor's report includes an emphasis of matter regarding a legal issue involving the revocation of lease rights by MIDC for land valued at ₹320.02 crore, which is currently under litigation at the Bombay High Court.

Morgan Ventures Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The trading window for dealing in the company's securities remains closed from April 1, 2026, and will open 48 hours after the declaration of the financial results.

Morgan Ventures Ltd responded to a stock exchange query regarding significant share price movement. The company stated that it has consistently disclosed all material information relevant to its operations and performance, adhering to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Morgan Ventures further clarified that it is unaware of the specific reasons behind the recent significant movement in its share price, attributing it purely to market-driven factors. The management explicitly denied any connection or involvement with the share price fluctuations and reiterated its commitment to ongoing compliance with all applicable listing regulations and laws.

Morgan Ventures Ltd has announced the closure of its trading window in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct-Prohibition of Insider Trading. The closure will be effective from April 01, 2026 until 48 hours after the declaration and submission of the financial results for the year ended March 31, 2026 to the Stock Exchanges. Promoters, directors, designated persons, connected persons, and their immediate relatives are advised not to trade in the company's securities during this period.

Morgan Ventures Ltd has announced its unaudited financial results for the quarter and nine months ended 31st December 2025. The company's revenue from operations stands at ₹ 1,600.82 lakhs for the quarter and ₹ 19,378.90 lakhs for the nine months. The net profit for the quarter is ₹ 423.10 lakhs and ₹ 1,416.42 lakhs for the nine months. The company's total expenses for the quarter are ₹ 7,124.10 lakhs and ₹ 18,180.27 lakhs for the nine months.